Αποτελέσματα Αναζήτησης
ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Chronic Coronary Syndromes.
- Clinical Practice Guidelines
ESC Clinical Practice Guidelines aim to present all the...
- Clinical Practice Guidelines
ESC Clinical Practice Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision-making.
31 Αυγ 2019 · Rivaroxaban is a factor Xa inhibitor that has been studied at a low dose of 2.5 mg b.i.d. in several populations of patients in sinus rhythm, this dose being one-quarter of the standard dose used for anticoagulation in patients with AF.
25 Αυγ 2021 · This guideline provides practical, evidence-based recommendations. The format of the previous 2016 ESC HF Guidelines was revised to make each phenotype of HF stand alone in terms of its diagnosis and management.
14 Ιαν 2020 · 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41 (3):407-477. doi: 10.1093/eurheartj/ehz425.
6 Σεπ 2019 · In the current guidelines on CCS, six clinical scenarios most frequently encountered in patients are identified: (i) patients with suspected CAD and “stable” anginal symptoms, and/or dyspnea; (ii) patients with new onset of heart failure (HF) or left ventricular (LV) dysfunction and suspected CAD; (iii) asymptomatic and symptomatic patients ...
19 Μαΐ 2020 · In this article, we summarize the recommendations for cardiovascular imaging in the assessment of patients with suspected obstructive CAD in the 2019 ESC guidelines together with recent data underlying the recommendations.
